Lisanti Capital Growth’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,355
| Closed | -$652K | – | 117 |
|
|
2024
Q3 | $652K | Sell |
12,355
-26,800
| -68% | -$1.42M | 0.17% | 111 |
|
|
2024
Q2 | $2.12M | Buy |
39,155
+21,350
| +120% | +$1.16M | 0.51% | 75 |
|
|
2024
Q1 | $1.25M | Sell |
17,805
-32,675
| -65% | -$2.29M | 0.3% | 98 |
|
|
2023
Q4 | $4.21M | Buy |
+50,480
| New | +$4.21M | 0.99% | 44 |
|
|
2022
Q4 | – | Sell |
-169,767
| Closed | -$8.23M | – | 134 |
|
|
2022
Q3 | $8.23M | Sell |
169,767
-163,505
| -49% | -$7.92M | 1.1% | 32 |
|
|
2022
Q2 | $13.1M | Buy |
333,272
+68,574
| +26% | +$2.69M | 1.78% | 15 |
|
|
2022
Q1 | $9.74M | Buy |
264,698
+45,838
| +21% | +$1.69M | 1.09% | 27 |
|
|
2021
Q4 | $9.98M | Buy |
+218,860
| New | +$9.98M | 1.44% | 16 |
|